A Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid Tumors

NCT06952010 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Advanced Solid Tumor
Metastatic Solid Tumor
Immune Sensitive Tumor

Interventions

BIOLOGICAL: XB628

Sponsor

Exelixis